Press "Enter" to skip to content

Novartis to bolster its oncology portfolio with acquisition of MorphoSys

https://www.marketwatch.com/story/novartis-to-bolster-its-oncology-portfolio-with-acquisition-of-morphosys-6b167583?mod=mw_rss_topstories
Novartis AG on Monday announced it has agreed to buy German biopharmaceutical company MorphoSys AG for 2.7 billion euros ($2.9 billion…

More from BusinessMore posts in Business »
More from UncategorizedMore posts in Uncategorized »